Related Experiment Video
Updated: Aug 15, 2026

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
Published on: December 4, 2007
The hazards of retroviruses associated with monoclonal antibody production
Abstract:
The majority of mammalian cells contain in their chromosomes genetic information related to retroviruses. Mice, and in particular, the inbred strains used in laboratory studies, have a number of different types of these viruses and murine cell lines frequently express virus. Retrovirus production has been noted in a number of myeloma cell lines and in hybridomas prepared from them. Therefore crude monoclonal antibody preparations may contain large numbers of these viruses. Retroviruses have been shown to be capable of activating or of acquiring oncogenes from cells. They may also recombine with endogenous leucosis virus to produce a recombinant virus with pathogenic properties. Comparison of endogenous cell DNA and retrovirus sequences has shown that retroviruses are capable of crossing genus and even class barriers. Retroviruses that are harmless in one species may be pathogenic in another. Hence care is required in the manufacturing and quality control procedures applied to monoclonal antibodies, particularly with products intended for medical and veterinary use. Widespread inoculation of retroviruses into a range of animal species may result only in trauma for the occasional individual but it is not possible to preclude the formation of a new type of pathogenic agent that can spread throughout the population.
Insights
Mammalian cells contain retroviral genetic information. Crude monoclonal antibody preparations may harbor these viruses, posing risks of oncogene activation and novel pathogen emergence, necessitating careful manufacturing and quality control.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- Mammalian cells, particularly laboratory mice, harbor endogenous retroviral genetic information.
- Murine cell lines, myeloma cell lines, and hybridomas frequently express retroviruses.
- Crude monoclonal antibody preparations can contain significant numbers of retroviruses.
Purpose of the Study:
- To highlight the potential risks associated with retroviruses in monoclonal antibody production.
- To emphasize the need for stringent manufacturing and quality control procedures.
- To inform about the pathogenic potential of retroviruses across species barriers.
Main Methods:
- Review of existing literature on retroviral presence in mammalian cells and monoclonal antibody production.
- Analysis of retroviral mechanisms for oncogene activation and recombination.
- Comparison of endogenous retroviral sequences with exogenous ones.
Main Results:
- Retroviruses can activate or acquire oncogenes, and recombine to form pathogenic agents.
- Retroviruses can cross species barriers, exhibiting different pathogenicity.
- Crude monoclonal antibodies may contain infectious retroviruses.
Conclusions:
- Careful manufacturing and quality control are essential for monoclonal antibody production, especially for medical and veterinary use.
- Widespread retroviral inoculation carries the risk of creating new, transmissible pathogenic agents.
- Understanding retroviral behavior is critical to prevent unintended consequences in biological products.
Related Concept Videos
Retrovirus Life Cycles
Humoral Immune Responses
Retroviruses
Mechanisms of Retrovirus-induced Cancers
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cytomegalovirus Disease

